Malaya United Trading Inc. · Makati, Philippines

Building the
infrastructure for
accessible screening.

Malaya United is building the healthcare infrastructure needed to make advanced cervical screening accessible across the Philippines. It pairs logistics expertise with clinical partnerships to close the cervical-screening gap.

Our mission Leadership
Mission

Cervical cancer is one of the most preventable cancers. We're closing the last mile.

Founded to bridge the gap between proven HPV-DNA screening science and the millions of Filipino women who never reach a clinic, Malaya United Trading Inc. combines a manufacturing partnership with eDNA Teknoloji (Türkiye), a logistics-first distribution model, and active engagement with Philippine public health policy.

Persistent infection with high-risk HPV is the main cause of cervical cancer. CarciScan is a PCR-based HPV DNA screening assay designed to identify high-risk HPV in eligible samples; the result helps determine which women need further clinical evaluation, closing the gap between infection and diagnosis before it becomes disease.

That same last-mile thinking shapes how a sample reaches the lab: community-based collection at barangay health posts, a documented chain of custody, and controlled cold-chain handling that carries each specimen from a Filipino community to a qualified PCR laboratory and back with a secure digital result. It's this connective infrastructure, not the science alone, that Malaya United is built to deliver.

Philippine SEC Reg. No. 2026080263365-02 PH FDA License to Operate (LTO) — medical device distributor-importer/wholesaler Makati, Philippines Protect her future. Screen early.

A look inside CarciScan's community-based HPV-DNA screening model, from sample collection to laboratory analysis.

Laboratory science, in motion
The access gap

Science already exists.
Access is the missing infrastructure.

Advanced HPV-DNA screening technology has existed for years. The reason it still doesn't reach most Filipino women has never been a scientific one.

  1. 01

    The science already exists.

    PCR-based HPV DNA screening is established, well-understood laboratory technology, sensitive enough to identify high-risk HPV long before it becomes disease. That part of the problem was solved years ago.

  2. 02

    Yet many women remain outside the pathway.

    Distance, cost, and the simple absence of a nearby facility keep millions of Filipino women outside any effective screening pathway. Not because the science can't reach them, but because the pathway to it usually doesn't.

  3. 03

    A laboratory result alone is not enough.

    An accurate result sitting inside a laboratory changes nothing for a woman who never learns it, or who has nowhere to go once she does. Science becomes care only when a result actually reaches a person, and is acted on.

  4. 04

    Access is a chain, not a single step.

    Reaching a woman with a real answer requires specimen collection, a laboratory with the capacity to process it, logistics that protect the specimen along the way, a secure digital pathway for the result, and a clinician to act on a referral. Break any one link and the chain fails quietly.

  5. 05

    Malaya United is building that chain in the Philippines.

    Malaya United is assembling the infrastructure that connects community-based specimen collection by trained clinical staff — with self-collection a future roadmap goal, to be validated through research — laboratory processing, cold-chain logistics, secure digital results, and clinical referral and follow-up into a single working pathway, built to reach every barangay, not only the capital.

  6. 06

    The intended outcome: access, confidence, and freedom.

    When the chain holds, a woman doesn't have to choose between distance and prevention. The intended outcome isn't only a result. It's the confidence of knowing, and the freedom that comes from having somewhere to go next.

The outcome we're building toward
Our story

Behind every test is a person.

Why we are building the whole path around CarciScan, not only bringing a test to the Philippines.

We founded Malaya United because whether a woman in the Philippines is screened for cervical cancer should not depend on what she earns or where she lives. Too often, it still does.

Behind every test is a person: a mother, a daughter, a partner, a friend. She has hopes, people who rely on her and a future worth protecting. To us, a sample is never just a sample.

The science to find high-risk HPV early already exists. What is often missing is the path around it: information she can trust, a screening site close to home, a sample that reaches the laboratory safely, a result she can understand and someone at her side when follow-up is needed. Each of these steps exists somewhere. Too often, they are not connected.

That is what moves us. We are building the ecosystem behind CarciScan to join these separate steps into one reliable path, so that every woman can be screened, understand her result and get support with what comes next.

Every woman deserves a clear path to care.

In place today
Malaya United holds a Philippine FDA License to Operate as a medical device distributor-importer and wholesaler, and is the exclusive distributor of CarciScan, the laboratory HPV DNA assay made by eDNA Teknoloji in Türkiye.
What we are building now
The operations platform, the patient app and the network of screening sites, partner laboratories, cold-chain logistics and patient navigation that the path needs. We are building and connecting them step by step.

Explore the journey

Five stations every woman passes through, from a first question to the care she needs. Select a station to see the challenge she faces there and how our ecosystem is being built to support her.

1Awareness Why should I get screened?

Her challenge
She feels healthy, has rarely heard about HPV and is not sure screening is meant for someone like her.
How our ecosystem will support her
Clear, respectful information brought into her community with local government health units, screening sites and community health workers: what HPV screening is, who it is for and why finding changes early matters.

2Access & Sampling Where can I take the first step?

Her challenge
The nearest place to be tested can be far away and costly to reach, and she does not know what will happen to her there.
How our ecosystem will support her
Screening sites close to where women live, a simple registration with her own patient record and QR code, and a sample collected by a trained clinician with privacy and dignity.

3Logistics & Laboratory Where does my sample go?

Her challenge
Once her sample leaves the site she cannot see where it goes, and a sample that is lost or badly stored means waiting and being tested again.
How our ecosystem will support her
A recorded chain of custody: every tube labelled by barcode, carried in the cold chain to a qualified partner laboratory and tested with CarciScan by PCR, with each result approved by the laboratory head.

4Results & Understanding What does my result mean?

Her challenge
Waiting is hard, and a result written in medical language can leave her more worried than before.
How our ecosystem will support her
A secure notification when her result is ready, a report in plain language that she can keep, and the clear message that a screening result is not a cancer diagnosis: a positive result means further clinical evaluation is needed.

5Follow-up & Care Who helps me next?

Her challenge
A positive result raises the hardest question: where does she go now, and who will help her get there?
How our ecosystem will support her
Patient navigation that follows every positive result, refers her to appropriate clinical care and stays with her until the next step is done, and a reminder for every woman when it is time to screen again.

We cannot build this path alone. We are looking for health units, screening sites, laboratories and partners who share the goal.

Help us bring this journey to more women
The CarciScan ecosystem

One QR code per woman, one connected pathway.

Around the CarciScan assay, the Malaya Operations Platform connects government and LGUs, screening sites, partner laboratories, patient navigators and the cold chain, from registration to result to follow-up.

Explore the ecosystem →
How it works

A screening pathway built for every barangay, not just the capital.

Distance shouldn't decide whether a woman can access prevention. Malaya United's model is designed to carry a sample from a community health post to a qualified laboratory and back again, even across islands and hard-to-reach communities. In much of the Philippines, the nearest laboratory capable of running a PCR-based HPV DNA test is a boat ride and hours of travel away, not a short walk from a barangay health post. Rather than asking every woman to make that journey herself, the model is built to bring the same standard of testing to her: a documented chain of custody carries each sample from collection through cold-chain transport to a qualified laboratory, with a secure digital result returned along the same route. Holding that chain together, island by island and barangay by barangay, is what closes the distance between where a woman lives and where prevention actually happens.

The Flexible Malaya program film: community-based HPV screening access, from outreach to laboratory result.

Community access Sample transport Cold-chain handling PCR laboratories Digital results Follow-up care
01

Community access

Screening starts where women already are: barangay health posts and community outreach, not only distant clinics.

02

Documented sample transport

Each collected sample is logged and carried under a documented chain of custody from the community to the lab network.

03

Controlled cold-chain handling

Samples are kept under controlled cold-chain conditions in transit, protecting sample integrity across long-distance routes.

04

Qualified PCR laboratories

Testing runs on a PCR-based HPV DNA assay in a qualified laboratory setting, built for accuracy over speed.

05

Secure digital results

Results are returned through a secure digital pathway, so a woman and her care team aren't waiting on paper in transit.

06

Accountable follow-up care

A positive result is connected to further clinical evaluation, closing the loop instead of leaving a result unread.

Screening results are not a cancer diagnosis. A positive result indicates a need for further clinical evaluation, not a confirmed diagnosis.

Built for national scale. Designed to reach every barangay.

Protect her future. Screen early.
Leadership

Leadership & Organization

Malaya United's board, leadership and operating team. Tap or hover a card to read more.

Ace John Oliver Vollbrecht

Founder & CEO

Malaya began with a simple conviction: access to cervical cancer prevention should not depend on a woman’s income, address or distance from a major hospital.

Board & Leadership

Gabriel Patrick Tanangco

Chief Executive Advisor (CEA)

My role as Chief Executive Advisor is to help connect Malaya’s strategy with the institutions, partners and stakeholders a national screening effort depends on. Good strategy only matters if it can be coordinated and executed across many moving parts. That coordination, quietly done, is where I try to add the most value.

Heiner Fernando Engelbach

Vice President (VP)

I have spent over a decade building businesses in real estate and hospitality across two countries, and the lesson holds everywhere: sustainable growth is built on discipline, not shortcuts. My responsibility is to make sure Malaya grows at a pace our finances, our partners and our patients can trust.

Key responsibilities
  • Build & manage strategic partnerships
  • Liaison with DOH, PhilHealth and other government agencies
  • MOUs and agreements
  • Stakeholder engagement
  • Partnership reporting

Atty. Gino Cuison

Corporate Secretary (Also the Company's Lawyer)

Key responsibilities
  • Ensure compliance with laws, rules, and corporate governance guidelines
  • Advise the Board and Management on legal matters and corporate risks
  • Oversee corporate records, contracts and legal documentation
  • Ensure proper conduct of Board and Shareholders' meetings
  • Safeguard corporate governance standards and ethical practices

Aime Wöhlert

Executive Assistant to President/CEO

Over twenty years of managing businesses has taught me that good intentions need good execution behind them: clear records, accountable processes, people who know their roles. I make sure Malaya’s governance is as dependable as the science we are building our reputation on.

Asena Vollbrecht

Administrative Secretary

For me, Malaya is about turning care into action. As a woman and a member of a family, I understand how deeply one person’s health can affect the people around them. Being part of Malaya means being part of something that can create a healthier future, one woman, one family, and one generation at a time.

Thorsten Franke

Non-Executive Director

As a Non-Executive Director, my role is to bring a perspective that is not caught up in day-to-day operations. I ask the questions that keep us honest about risk, pace and long-term consequences. Malaya’s mission is generational; my job is to help make sure our decisions along the way earn that horizon.

Aslihan Ataselim

Non-Executive Director

For me, Malaya is about turning care into action. As a woman and a member of a family, I understand how deeply one person’s health can affect the people around them. Being part of Malaya means being part of something that can create a healthier future, one woman, one family, and one generation at a time.

Executive Officers & Advisory

Achilles Lapore Beriña II

Chief Medical Officer (CMO)

As a nurse, I have cared for patients across three health systems, and one truth holds everywhere: a screening result only matters if it is accurate and reaches the woman with care behind it. I hold our laboratory process, sample handling and patient communication to that same clinical standard, without exception.

Key responsibilities
  • Medical strategy
  • Quality assurance
  • Medical advisory
  • Coordination with DOH & PhilHealth
  • Oversight of medical programs

Enrique Inukai

Chief Financial Officer

Key responsibilities
  • Financial planning & budgeting
  • Accounting & reporting
  • Compliance & audit
  • Risk management
  • Financial control
  • Donor & investor reporting

James Martin

Chief Technology Officer (CTO) & B Scale

Key responsibilities
  • IT strategy & systems
  • System maintenance & security
  • Data management
  • Process digitalization
  • IT support & infrastructure

Rapha Israel Bacud

Director of Warehousing and Logistics

As an engineer who has worked on public infrastructure, I know access is only real when the last mile actually works, on time, every time. My role is to build the warehousing and distribution backbone so a screening kit reaches a community reliably, not occasionally.

Key responsibilities
  • Demand planning with Program Teams & CMOs
  • Coordination with RAF Logistics
  • Inventory monitoring across warehouses
  • Quality assurance
  • Receiving & outbound distribution coordination
  • Stock reports

Jaime Jr. Adriano

Head of Social Impact and Community Programs

My earlier work as a paramedic meant meeting people on some of their hardest days. That shapes how I think about screening access: it has to reach the communities furthest from a clinic, not only the ones closest. Our social impact work exists so no woman is left out because of where she lives.

Key responsibilities
  • Social program development
  • Community engagement
  • Program implementation oversight
  • Impact measurement & reporting

Operating Team

Nico Villanueva

Human Resources Manager

Key responsibilities
  • Recruitment & onboarding
  • Employee relations
  • Performance management
  • Learning & development
  • HR policies & compliance
  • Employee well-being

Dennis Ebora

Marketing Manager

Marketing a screening product carries a responsibility beyond growth numbers: the words we choose can decide whether a woman trusts a test enough to take it. My focus is communication that is accurate, respectful and never overstates what CarciScan can do, because trust is what actually drives access.

Dennis Marzoña

Sales Manager

Sales, for a screening product, is really about access: getting CarciScan in front of the clinics, laboratories and partners who can put it within reach of more women. I focus on building those relationships honestly, on the product’s real capabilities, so access grows on a foundation that lasts.

Partner ecosystem

Five relationships, one pathway.

From manufacturing to scientific alignment, each partner strengthens a distinct link in the CarciScan pathway.

eDNA

Manufacturing & Biotechnology

Manufacturing and biotechnology partner supporting the CarciScan platform.

genoma

Diagnostic Technology

Diagnostic technology and product ecosystem behind CarciScan.

Brand Activation Setup

Supply & Market Access

Supply coordination, international distribution and business setup.

The Majlis Collective

Global Health Exchange

Dialogue connecting healthcare, culture, diplomacy and collaboration.

ESGO

Scientific Network

Professional oncology network supporting scientific exchange and global alignment.

Inclusion does not by itself imply endorsement, procurement, exclusivity or institutional approval.

Contact

Let's talk: investors, clinics, and partners welcome.

For data-room access, clinical partnerships, or distribution inquiries, reach the Malaya United team directly.

General & Investor Relations

Ace John Oliver Vollbrecht
President & CEO

Registered Office

Makati, Philippines
Philippine SEC Reg. No. 2026080263365-02

Product & Clinical

CarciScan product overview and evidence base.

View product & evidence →

Ready to talk?

For partnerships, media, or general questions, reach the Malaya United team directly.

Get in touch Explore the product